Moderna Therapeutics racks up $500 mln
Cambridge, Massachusetts-based Moderna Therapeutics, a developer of messenger RNA therapeutics and vaccines, has raised $500 million in funding. The investors include a subsidiary of the Abu Dhabi Investment Authority, EDBI, Sequoia Capital China, Fidelity Management & Research Company, Pictet, Viking Global Investors, ArrowMark Partners and Alexandria Venture Investments.
2 February 2018•1 min read
